Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05625971Completed

Non-invasive MRD Assessment in Multiple Myeloma

Role: collaborator

NCT03063918Not ApplicableCompleted

Personalized Dietary Intervention in Managing Bowel Dysfunction and Improving Quality of Life in Stage I-III Rectosigmoid Cancer Survivors

Role: collaborator

NCT00587301Not ApplicableCompleted

Lap-Band Surgery on Adolescents for Safety and Efficacy

Role: collaborator

NCT01512875Completed

S1119 Peruvian H. Pylori Water Contamination Study

Role: collaborator

All 4 trials loaded